Pharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM®
Clinical trial NCT01320410 · COMPLETED
Trial details
- NCT number
- NCT01320410
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.